Health & bio

CMS Launches July 2026 Medicare GLP-1 Obesity Pilot

May 6 CMS announced GLP-1 bridge model (July 2026–December 2027) offering discount coverage for Wegovy, Zepbound KwikPen, Foundayo tablets for Medicare enrollees with BMI 27+ (with comorbidities) or BMI 35+.

Primary sources · 2
NPRCMS
Related storylines
#2026-W14-04 · GLP-1 market enters triple inflection point: oral agents, insurance cliff, and end of 503B compounding
← View the full 2026-05-10 (Sunday) issue
What you're reading now arrives in your inbox daily at 21:00 UTC.

Get today's brief every day at 21:00 UTC

7 must-reads · 17 fields · tracked storylines delivered to your inbox daily. Pick only the fields you want; unsubscribe anytime.

Past issues →